Clinical Trials in Gilbert, Arizona

Find clinical trials in Gilbert, Arizona. Discover local research opportunities and treatment options in your area.

151 Active Trials Found in Gilbert

Showing 151 trials on this page

Page 1 of 8

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT ID: NCT04267848

The ALCHEMIST trial is a clinical study looking at whether adding a drug called pembrolizumab, which is a type of immunotherapy, to standard chemotherapy can improve treatment outcomes for patients...

Recruiting

Phase: PHASE3 Conditions: Stage IIIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 +4 more

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

This clinical trial is studying a new treatment called elranatamab to see if it is more effective than a standard treatment called lenalidomide for patients with newly diagnosed multiple myeloma wh...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT ID: NCT05877599

This clinical trial is studying a new treatment called NT-175 for adults with advanced solid tumors, which are types of cancer that cannot be removed by surgery. Specifically, this trial focuses on...

Recruiting

Phase: PHASE1 Conditions: Breast Cancer, Ovarian Cancer +5 more

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

NCT ID: NCT06118281

The ARTEMIS clinical trial is investigating a new medication called ziltivekimab, which researchers hope can help people who have recently had a heart attack. The goal is to see if ziltivekimab can...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Risk, Acute Myocardial Infarction (AMI)

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT ID: NCT06312176

This clinical trial is studying a new treatment option for patients with a specific type of breast cancer called hormone receptor positive and HER2 negative (HR+/HER2-). The researchers want to see...

Recruiting

Phase: PHASE3 Conditions: Breast Neoplasms

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

NCT ID: NCT06551324

This clinical trial, called MEVPRO-1, is looking at a new medicine called PF-06821497 (Mevrometostat) to see if it can help men with metastatic castrate-resistant prostate cancer (mCRPC) who have p...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castrate Resistant Prostate Cancer (mCRPC)

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06629779

This clinical trial is studying a new drug called PF-06821497 (also known as Mevrometostat) to see if it works better when combined with another medication called enzalutamide for men with metastat...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castration-Resistant Prostate Cancer

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

NCT ID: NCT06380751

This clinical trial is studying a new combination treatment for patients with advanced breast cancer that is hormone receptor-positive and HER2-negative. The researchers want to see if the drug sar...

Recruiting

Phase: PHASE3 Conditions: Advanced Breast Cancer

A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features

NCT ID: NCT06564844

This clinical trial is investigating a new treatment approach for patients with Stage I adenocarcinoma non-small cell lung cancer (NSCLC) who have had their tumors completely removed through surger...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT ID: NCT07000357

This clinical trial is studying a medication called AZD0780 to see if it can help reduce serious heart-related events in patients who have a history of cardiovascular disease or are at high risk fo...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Disease

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

NCT ID: NCT05323253

This clinical trial is studying a new treatment called Alpha DaRT224 for patients with recurrent skin cancer known as cutaneous squamous cell carcinoma (SCC). The goal is to see how effective and s...

Recruiting

Phase: NA Conditions: Recurrent Squamous Cell Carcinoma

A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

NCT ID: NCT06747949

This clinical trial is studying a medication called dazodalibep to see how safe it is for people with Sjögren's Syndrome when taken over a longer period of time. Sjögren's Syndrome is an autoimmune...

Recruiting

Phase: PHASE3 Conditions: Sjögren's Syndrome

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT ID: NCT06858878

This clinical trial is exploring a new medication called maridebart cafraglutide to see how effective it is for adults with type 2 diabetes who are also overweight or have obesity. The main goal is...

Recruiting

Phase: PHASE3 Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

NCT ID: NCT05411081

The PAPMET2 trial is a research study that is exploring the effects of a new treatment combination for patients with advanced papillary kidney cancer, which is a type of kidney cancer that has spre...

Recruiting

Phase: PHASE2 Conditions: Stage IV Renal Cell Cancer AJCC v8, Metastatic Papillary Renal Cell Carcinoma

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT ID: NCT06722157

This clinical trial is investigating a new treatment called BI 771716 for people aged 50 and older who have an advanced eye condition known as geographic atrophy, which is a type of age-related mac...

Recruiting

Phase: PHASE2 Conditions: Geographic Atrophy, Macular Degeneration, Age-related

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

NCT ID: NCT07000123

This clinical trial is studying a new medication called AZD0780, which is designed to lower levels of LDL cholesterol (often referred to as "bad" cholesterol) in the blood. The trial is for adults ...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Disease

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

NCT ID: NCT05894239

This clinical trial is studying a new treatment for patients with a specific type of advanced breast cancer known as HER2-positive metastatic breast cancer. The researchers want to find out if a dr...

Recruiting

Phase: PHASE3 Conditions: Metastatic Breast Cancer

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

NCT ID: NCT06497556

This clinical trial is studying a new treatment called divarasib for patients with advanced or metastatic non-small cell lung cancer (NSCLC) that has a specific mutation known as KRAS G12C. The goa...

Recruiting

Phase: PHASE3 Conditions: Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

NCT ID: NCT07106762

This clinical trial is studying a new treatment called Izalontamab Brengitecan for people with advanced urothelial cancer, a type of bladder cancer that has spread to other parts of the body. The t...

Not yet recruiting

Phase: PHASE2 Conditions: Urothelial Cancer